EKF diagnostic GmbH's Unique And Simple Creamatocrit Analyzer Highlighted At FIGO
Inexpensive and accurate analysis of mother’s milk fat and calories
ideal for neonatal ICU
The Creamatocrit™ Plus system helps ensure premature infants receive the calories they need For high resolution image, please contact sarahp@alto-marketing.com
Cardiff, UK – 5th October 2015 – EKF Diagnostics, the global in vitro diagnostics company, announces that it is exhibiting its range of Maternal and Women's Health products at the XXI FIGO World Congress - the International Federation of Gynecology and Obstetrics - in Vancouver, Canada, 4-9th October. EKF’s portfolio in this sector has been tailor made to address the specific healthcare needs women face during pregnancy and in their everyday lives.
At Booth #919, EKF is highlighting its Creamatocrit Plus™ mother’s milk fat and calories analyzer. This novel centrifuge with built-in tube reader is the first and only system dedicated to providing a fast and accurate creamatocrit measure of mother’s milk and estimate of calories. Small and lightweight with whisper quiet 3-minute operation, Creamatocrit Plus™ is particularly useful in neonatal intensive care units (NICU) to ensure that premature infants are receiving the calories that they need to thrive.
Creamatocrit Plus™ guides the separation of foremilk and the high lipid, high caloric hindmilk to accelerate weight gain in extremely low birthweight infants. To achieve this it uses a very simple, inexpensive and accurate technique for estimating the lipid concentration and calorific density in mothers’ milk – a video demonstration of this simple technique is available at www.ekfdiagnostics.com/Creamatocrit_Plus_1536.aspx
Other EKF products being exhibited on Booth #919 at FIGO include its CLIA waived point-of-care pregnancy tests, Diaspect Tm hemoglobin analyzer and Lactate Scout+ lactate analyzer.
Pre-natal lactate testing seminar
Notably, EKF will also host a workshop entitled ‘Lactate in the peripartum period’ where eminent obstetricians will present on this key measure of fetal well-being. Professor Gian Carlo Di Renzo, FIGO Honorary Secretary, Perugia University, Italy, will provide an overview on ‘Lactate in Obstetrics’. Professor Wolfgang Henrich and Dr Johanna Stuckenschneider, Obstetrics and Gynecology Hospital Charite-Berlin, Germany, will discuss ‘Dystocia management and the impact of using a lactate point-of-care device.’ The workshop will be held on Wednesday 7th October, 12.00-1.30pm, in Room 101-102, Level 1, West Building Convention Centre.
The FIGO World Congress of Gynecology and Obstetrics is a key conference in this field as it uniquely brings together professional societies of obstetricians and gynecologists on a global basis. It is one of the largest international gatherings of obstetricians, gynecologists, midwives, nurses, general practitioners and other specialists working in the field of women’s health. With member societies in 125 countries or territories, over 7,000 delegates from around the world are expected to attend.
For more information on EKF Diagnostics and its range of Maternal and Women's Health products, please visit: www.ekfdiagnostics.com
Editors’ notes
About EKF Diagnostics - www.ekfdiagnostics.com
EKF Diagnostics Holdings plc, which includes the EKF Diagnostics, EKF Molecular, Stanbio Laboratory, Separation Technology Inc., DiaSpect and Selah Genomics brands, specializes in the development, production and worldwide distribution of point-of-care blood analyzers for use in the detection and management of diabetes, anemia, lactate and kidney related diseases. Its new molecular division, EKF Molecular Diagnostics, focuses on technology used within the development of companion diagnostics, specifically within oncology. EKF products are sold in more than 100 countries around the globe, through a network of specialist distributors.
Point-of-care diagnostics: EKF Diagnostics designs and manufactures world-class diagnostic devices, as well as distributing rapid test kits for infectious diseases and pregnancy. The EKF analyzer range is used widely in GP surgeries, pharmacies, blood banks, sports clinics, hospitals and laboratories for glucose, lactate, hemoglobin, hematocrit and HbA1c measurement.
Central laboratory: EKF, through its wholly owned subsidiary, Stanbio Laboratory (Boerne, Texas, USA), manufactures a comprehensive range of clinical chemistry reagents. In addition, EKF Life Sciences (Elkhart, Indiana, USA) manufactures enzymes used in reagent development and also provides contract fermentation facilities.
Molecular Diagnostics: In March 2013 EKF set up a new division to focus on molecular and companion diagnostics following the acquisition of UK-based 360 Genomics. EKF Molecular Diagnostics’ technology, PointMan™, is capable of detecting mutant genes from tiny biopsy and blood samples and has recently entered a partnership with the world renowned cancer research center at Massachusetts General Hospital, USA.
EKF Diagnostics’ strengths lie in its multi-national research and manufacturing facilities, teams of experienced analysts and engineers in Germany, Ireland, USA and the UK, and a board led by some of world’s foremost authorities in medical diagnostics.
Help employers find you! Check out all the jobs and post your resume.
The Creamatocrit™ Plus system helps ensure premature infants receive the calories they need For high resolution image, please contact sarahp@alto-marketing.com
Cardiff, UK – 5th October 2015 – EKF Diagnostics, the global in vitro diagnostics company, announces that it is exhibiting its range of Maternal and Women's Health products at the XXI FIGO World Congress - the International Federation of Gynecology and Obstetrics - in Vancouver, Canada, 4-9th October. EKF’s portfolio in this sector has been tailor made to address the specific healthcare needs women face during pregnancy and in their everyday lives.
At Booth #919, EKF is highlighting its Creamatocrit Plus™ mother’s milk fat and calories analyzer. This novel centrifuge with built-in tube reader is the first and only system dedicated to providing a fast and accurate creamatocrit measure of mother’s milk and estimate of calories. Small and lightweight with whisper quiet 3-minute operation, Creamatocrit Plus™ is particularly useful in neonatal intensive care units (NICU) to ensure that premature infants are receiving the calories that they need to thrive.
Creamatocrit Plus™ guides the separation of foremilk and the high lipid, high caloric hindmilk to accelerate weight gain in extremely low birthweight infants. To achieve this it uses a very simple, inexpensive and accurate technique for estimating the lipid concentration and calorific density in mothers’ milk – a video demonstration of this simple technique is available at www.ekfdiagnostics.com/Creamatocrit_Plus_1536.aspx
Other EKF products being exhibited on Booth #919 at FIGO include its CLIA waived point-of-care pregnancy tests, Diaspect Tm hemoglobin analyzer and Lactate Scout+ lactate analyzer.
Pre-natal lactate testing seminar
Notably, EKF will also host a workshop entitled ‘Lactate in the peripartum period’ where eminent obstetricians will present on this key measure of fetal well-being. Professor Gian Carlo Di Renzo, FIGO Honorary Secretary, Perugia University, Italy, will provide an overview on ‘Lactate in Obstetrics’. Professor Wolfgang Henrich and Dr Johanna Stuckenschneider, Obstetrics and Gynecology Hospital Charite-Berlin, Germany, will discuss ‘Dystocia management and the impact of using a lactate point-of-care device.’ The workshop will be held on Wednesday 7th October, 12.00-1.30pm, in Room 101-102, Level 1, West Building Convention Centre.
The FIGO World Congress of Gynecology and Obstetrics is a key conference in this field as it uniquely brings together professional societies of obstetricians and gynecologists on a global basis. It is one of the largest international gatherings of obstetricians, gynecologists, midwives, nurses, general practitioners and other specialists working in the field of women’s health. With member societies in 125 countries or territories, over 7,000 delegates from around the world are expected to attend.
For more information on EKF Diagnostics and its range of Maternal and Women's Health products, please visit: www.ekfdiagnostics.com
Editors’ notes
About EKF Diagnostics - www.ekfdiagnostics.com
EKF Diagnostics Holdings plc, which includes the EKF Diagnostics, EKF Molecular, Stanbio Laboratory, Separation Technology Inc., DiaSpect and Selah Genomics brands, specializes in the development, production and worldwide distribution of point-of-care blood analyzers for use in the detection and management of diabetes, anemia, lactate and kidney related diseases. Its new molecular division, EKF Molecular Diagnostics, focuses on technology used within the development of companion diagnostics, specifically within oncology. EKF products are sold in more than 100 countries around the globe, through a network of specialist distributors.
Point-of-care diagnostics: EKF Diagnostics designs and manufactures world-class diagnostic devices, as well as distributing rapid test kits for infectious diseases and pregnancy. The EKF analyzer range is used widely in GP surgeries, pharmacies, blood banks, sports clinics, hospitals and laboratories for glucose, lactate, hemoglobin, hematocrit and HbA1c measurement.
Central laboratory: EKF, through its wholly owned subsidiary, Stanbio Laboratory (Boerne, Texas, USA), manufactures a comprehensive range of clinical chemistry reagents. In addition, EKF Life Sciences (Elkhart, Indiana, USA) manufactures enzymes used in reagent development and also provides contract fermentation facilities.
Molecular Diagnostics: In March 2013 EKF set up a new division to focus on molecular and companion diagnostics following the acquisition of UK-based 360 Genomics. EKF Molecular Diagnostics’ technology, PointMan™, is capable of detecting mutant genes from tiny biopsy and blood samples and has recently entered a partnership with the world renowned cancer research center at Massachusetts General Hospital, USA.
EKF Diagnostics’ strengths lie in its multi-national research and manufacturing facilities, teams of experienced analysts and engineers in Germany, Ireland, USA and the UK, and a board led by some of world’s foremost authorities in medical diagnostics.
Help employers find you! Check out all the jobs and post your resume.